Pre-treatment with a novel synthetic TLR4 agonist prior to challenge with mouse-adapted H1N1 and H2N3 influenza strains reduced morbidity and mortality in BALB/c mice von Whitacre, Margaret, Ward, Janine, Jackson, Konner, Bess, Laura, Jayah, Rachel, Sands, Cherrokee, Arayangkul, Hathaipat, Khalaf, Juhienah K, Miller, Shannon M, Evans, Jay T, Bazin, Helene G

Volltext